Portman Square Capital LLP Insulet Corp Put Options Transaction History

Portman Square Capital LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Jul 19, 2024	BUY	$161.02 - $206.98 $5.86 Million - $7.53 Million	36,400 Added 26.96%	171,400 $34.6 Million
Q1 2024 Apr 15, 2024	BUY	$163.6 - $209.11 $818,000 - $1.05 Million	5,000 Added 3.85%	135,000 $23.1 Million
Q3 2023 Oct 30, 2023	BUY	$154.67 - $290.89 $13.7 Million - $25.7 Million	88,400 Added 212.5%	130,000 $20.7 Million
Q2 2023 Jul 26, 2023	SELL	$272.48 - $330.23 $4.9 Million - $5.94 Million	-18,000 Reduced 30.2%	41,600 $12 Million
Q1 2023 May 04, 2023	BUY	$276.36 - $326.03 $2.05 Million - $2.41 Million	7,400 Added 14.18%	59,600 $19 Million

Q4 2022 Feb 23, 2023	BUY	$212.22 - $313.46 $11.1 Million - $16.4 Million	52,200 New	52,200 $15.4 Billion

619

63M

339K

953K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Portman Square Capital LLP with notifications on news.